# Different Treatment Options Used for Post Covid-19 Syndrome

> **NCT07722000** · NA · COMPLETED · sponsor: **Beni-Suef University** · enrollment: 90 (actual)

## Conditions studied

- COVID-19
- Post COVID-19 Syndrome
- Ginkgo Biloba
- Piracetam

## Interventions

- **DRUG:** Ginkgo biloba
- **DRUG:** Piracetam
- **DRUG:** Ginkgo biloba and Piracetam

## Key facts

- **NCT ID:** NCT07722000
- **Lead sponsor:** Beni-Suef University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-01
- **Primary completion:** 2023-12-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2026-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07722000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07722000, "Different Treatment Options Used for Post Covid-19 Syndrome". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07722000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*